OriGene Logo
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Calpain 1 cleaves and inactivates prostacyclin synthase in mesenteric arteries from diabetic mice Basic Res. Cardiol 2017 [PTGIS]

Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion PLoS ONE 2017 [IL6]

SDHD promoter mutations ablate GABP transcription factor binding in melanoma Cancer Res 2017 [ELF1]

Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection Mucosal Immunol 2017 [CXCL4]

View All Citations >>

spacer

33 TrueClone belong to family "ion channels: sodium"

divider

  Page: 1 of 2 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
SC122106NM_018400SCN3BSCN3B (untagged)-ORIGENE UNIQUE VARIANT 1 of Human sodium channel, voltage-gated, type III, beta (SCN3B),0
SC122120NM_000833GRIN2AGRIN2A (untagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 20
SC122161NM_000335SCN5ASCN5A (untagged)-Human sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 20
SC122684NM_004588SCN2BSCN2B (untagged)-Human sodium channel, voltage-gated, type II, beta (SCN2B)0
SC304060NM_014191SCN8ASCN8A (untagged)-Human sodium channel, voltage gated, type VIII, alpha subunit (SCN8A), transcript variant 14
SC307625NM_198056SCN5ASCN5A (untagged)-Human sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 10
SC309017NM_002977SCN9ASCN9A (untagged)-Human sodium channel, voltage-gated, type IX, alpha subunit (SCN9A)0
SC309816NM_199037SCN1BSCN1B (untagged)-Human sodium channel, voltage-gated, type I, beta (SCN1B), transcript variant b0
SC309880NM_006922SCN3ASCN3A (untagged)-Human sodium channel, voltage-gated, type III, alpha subunit (SCN3A), transcript variant 14
SC310915NM_001040151SCN3BSCN3B (untagged)-Human sodium channel, voltage-gated, type III, beta (SCN3B), transcript variant 21
SC310930NM_001040142SCN2ASCN2A (untagged)-Human sodium channel, voltage-gated, type II, alpha subunit (SCN2A), transcript variant 21
SC310931NM_001040143SCN2ASCN2A (untagged)-Human sodium channel, voltage-gated, type II, alpha subunit (SCN2A), transcript variant 30
SC312490NM_018400SCN3BSCN3B (untagged)-Human sodium channel, voltage-gated, type III, beta (SCN3B), transcript variant 10
SC316037NM_001081676SCN3ASCN3A (untagged)-Human sodium channel, voltage-gated, type III, alpha subunit (SCN3A), transcript variant 21
SC316038NM_001081677SCN3ASCN3A (untagged)-Human sodium channel, voltage-gated, type III, alpha subunit (SCN3A), transcript variant 30
SC316614NM_001099405SCN5ASCN5A (untagged)-Human sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 47
SC316617NM_001099404SCN5ASCN5A (untagged)-Human sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 33
SC325409NM_001134408GRIN2AGRIN2A (untagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 30
SC325448NM_001142348SCN4BSCN4B (untagged)-Human sodium channel, voltage-gated, type IV, beta (SCN4B), transcript variant 20
SC326381NM_001134407GRIN2AGRIN2A (untagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 10

 

pattern
Inc 5000 Healthcare Company